Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Opinion in Biotechnology
|
November 1, 2005
Functional assays for screening GPCR targets
William Thomsen, John Frazer, David Unett
Current Opinion in Molecular Therapeutics
|
January 25, 2005
Orphan GPCR target validation
William Thomsen, James Leonard, Dominic P Behan
Current Opinion in Investigational Drugs (London, England : 2000)
|
November 13, 2004
G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes
Christina Bjenning, Hussien Al-Shamma, William Thomsen, et al.
JCO Precision Oncology
|
January 7, 2022
Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance
William Thomsen, Luke Maese, Jennie Vagher, et al.
CNS Drug Reviews
|
April 15, 2006
ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety
Shigeyuki Chaki, Jun-ichi Yamaguchi, Hisaharu Yamada, et al.
The Journal of Pediatrics
|
November 3, 2022
Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists
Maria Carter-Febres, Michell Lozano-Chinga, William Thomsen, et al.
Pediatrics
|
April 4, 2018
A Novel Presentation of Littoral Cell Angioma and Lymphatic Malformations in a Neonate
Lindsey Gakenheimer-Smith, Jeffrey Mohlman, Kate VandenHeuvel, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2005
Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists
Shigeyuki Chaki, Takeo Funakoshi, Shiho Hirota-Okuno, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Opinion in Biotechnology
|
November 1, 2005
Functional assays for screening GPCR targets
William Thomsen, John Frazer, David Unett
Current Opinion in Molecular Therapeutics
|
January 25, 2005
Orphan GPCR target validation
William Thomsen, James Leonard, Dominic P Behan
Current Opinion in Investigational Drugs (London, England : 2000)
|
November 13, 2004
G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes
Christina Bjenning, Hussien Al-Shamma, William Thomsen, et al.
JCO Precision Oncology
|
January 7, 2022
Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance
William Thomsen, Luke Maese, Jennie Vagher, et al.
CNS Drug Reviews
|
April 15, 2006
ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety
Shigeyuki Chaki, Jun-ichi Yamaguchi, Hisaharu Yamada, et al.
The Journal of Pediatrics
|
November 3, 2022
Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists
Maria Carter-Febres, Michell Lozano-Chinga, William Thomsen, et al.
Pediatrics
|
April 4, 2018
A Novel Presentation of Littoral Cell Angioma and Lymphatic Malformations in a Neonate
Lindsey Gakenheimer-Smith, Jeffrey Mohlman, Kate VandenHeuvel, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2005
Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists
Shigeyuki Chaki, Takeo Funakoshi, Shiho Hirota-Okuno, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Page
of 2